Titles
- Interview with Ralph W. Moss2
- Investigational COVID-19 convalescent plasma2
- Letter from Joshua Lederberg to Edmund S. Morgan2
- Letter from Joshua Lederberg to Vartan Gregorian2
- Management of osteoporosis and the prevention of fragility fractures: a national clinical guideline2
- Management of stable angina: a national clinical guideline2
- Management of suspected bacterial urinary tract infection in adults: a national clinical guideline2
- Medicaid's most costly outpatient drugs2
- Medicaid's role for children with special health care needs: a look at eligibility, services, and spending2
- Millions of adults ages 50 and older rely on the Supplemental Nutrition Assistance Program (SNAP)2
- Network adequacy standards in California: how they work and why they matter2
- New regulations broadening employer exemptions to contraceptive coverage: impact on women2
- Parks After Dark evaluation report2
- Peripheral vascular atherectomy devices: premarket notification [510(k)] submissions : guidance for industry and Food and Drug Administration staff2
- Policy for temporary compounding of certain alcohol-based hand sanitizer products during the public health emergency: immediately in effect guidance for industry2
- Racial and ethnic disparities in influenza and pneumococcal immunization rates among Medicare beneficiaries2
- Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components2
- Reductions in deaths and hospitalizations associated with COVID-19 vaccinations among Medicare beneficiaries: full year 2021 estimates2
- Referencing approved drug products in ANDA submissions2
- Requests for feedback and meetings for medical device submissions: the Q-Submission Program : guidance for industry and Food and Drug Administration staff2